$6.24
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 232 full-time employees. The company went IPO on 2012-09-12. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. The company sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Country

US

CEO

Mr. Steven Fife

IPO date

2012

Employees

235

ISIN

US53222K2050

Key stats

Open

$6.25

Volume

125.62K

Market cap

$78.85M

Prev. close

$6.25

Impl / hst vl

-

Open interest

$0.00

$6.16

Day’s Range

$6.37

$3.90

52W Range

$11.71

Valuation

94
Valuation score
Strongly undervalued
P/E
13.69
P/S
0.40
P/B
2.36
Current ratio
1.96
Debt / Equity
-0.37
ROE
17.15%
Gross margin
79.02%
Income growth
393.48%
FCF growth
132.98

Jun

15

Dividends

The last payment date was Jun 15, 2026

Div. per Share

$0.05

Div. Yield

0.80%

Payout Ratio

-

Div. Growth YoY

11.11%

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.14
The top 4 analysts forecasts that 12-month price may increase by 14.42%, with a low of $5.05 and a high of $9.45
$5.05
Low
$7.14
Avg
$9.45
High
Current price

Earnings

Q1 ‘26 revenue
$43.72M
Q1 ‘26 net income
$1.36M
Revenue
Net income
Previous EPS
$0.15
Estimate EPS
$0.16
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply